First recall: August 2024 In August 2024, ProRx initiated a voluntary recall of more than 15,000 vials of compounded semaglutide and tirzepatide products
Management depends on symptom severity and may range from lifestyle modifications and medications (proton pump inhibitors, antacids) to surgical repair in refractory or complicated cases
NAMPT expression also correlates with high Nanog levels in patient-derived glioblastoma tumors, 8 pointing to the role of NAMPT in maintaining the treatment-refractory component of glioblastoma
Who will benefit, payers or patients, and in what ways
Intrinsic motivation and realistic expectations, assessed during a morpho-psychological consultation
This epigenetic dimension connects the research to the broader field of metabolic epigenetics that researchers studying longevity peptides like epitalon also work in